Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2026-01-08 @ 4:03 PM
Study NCT ID:
NCT03135834
Status:
COMPLETED
Last Update Posted:
2023-08-08
First Post:
2017-04-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-24
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-25
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-26
First Submit QC Date:
None
Study First Post Date:
2017-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-20
Results First Submit QC Date:
None
Results First Post Date:
2023-08-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-04
Last Update Post Date:
2023-08-08
Last Update Post Date Type:
ACTUAL